Atlas Trials

A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Triple Negative Breast Cancer, With a Run-in of Escalating Dose of P276-00 Added to Gemcitabine and Carboplatin

Clinical trial NCT01333137 · TERMINATED

Trial details

NCT number
NCT01333137
Sponsor
Piramal Enterprises Limited
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2011-08-01
Primary completion
2012-07-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.